naltrexone and Squamous Cell Carcinoma of Head and Neck

naltrexone has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cata, JP; Corrales, G; Gleber-Netto, FO; Gorur, A; Myers, JN; Patiño, M; Pickering, C; Rangel, R; Shi, T; Takahashi, H	1

Other Studies

1 other study(ies) available for naltrexone and Squamous Cell Carcinoma of Head and Neck

Article	Year
Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. Journal of cellular physiology, 2021, Volume: 236, Issue:11 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Head and Neck Neoplasms; Humans; Male; Mice, Inbred C57BL; Mice, Nude; Naltrexone; Narcotic Antagonists; Neoplasm Invasiveness; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Burden; Xenograft Model Antitumor Assays	2021

Article

Year

Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.

Journal of cellular physiology, 2021, Volume: 236, Issue:11

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Head and Neck Neoplasms; Humans; Male; Mice, Inbred C57BL; Mice, Nude; Naltrexone; Narcotic Antagonists; Neoplasm Invasiveness; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Burden; Xenograft Model Antitumor Assays

2021